How can we block sympathetic overactivity? Effects of rilmenidine and atenolol in overweight hypertensive patients
Author:
Publisher
Springer Science and Business Media LLC
Subject
Internal Medicine
Link
http://www.nature.com/articles/1002004.pdf
Reference53 articles.
1. Tatti P, Pahor M, Byington RP, Di Mauro P, Guarisco R, Strollo G et al. Outcome results of the fosinopril versus amlodipine cardiovascular events randomized trial (FACET) in patients with hypertension and NIDDM. Diabetes Care 1998; 21: 597–603.
2. Lindholm LH, Ibsen T, Dahlof B, Devereux RB, Beevers G, de Faire U et al. Cardiovascular morbidity and mortality in patents with diabetes in the Losartan Intervention For End-point reduction in hypertension study (LIFE): a randomized trial against atenolol. Lancet 2002; 359: 1004–1010.
3. Bousquet P, Dontenwill M, Greney H, Feldman J . Imidazoline receptors in cardiovascular and metabolic diseases. J Cardiovasc Pharmacol 2000; 35 (Suppl. 4): 21–25.
4. Krentz AJ, Evans AJ . Selective imidazoline receptors agonists for metabolic syndrome. Lancet 1998; 351: 152–154.
5. Pollare T, Lithell H, Selinus I, Berne C . Sensitivity to insulin during treatment with atenolol and metoprolol: a randomized, double blind study of effects on carbohydrate and lipoprotein metabolism in hypertensive patients. BMJ 1989; 298: 1152–1157.
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Centrally acting antihypertensives change the psychogenic cardiovascular reactivity;Fundamental & Clinical Pharmacology;2021-02-27
2. Potential Protective Role of Blood Pressure-Lowering Drugs on the Balance between Hemostasis and Fibrinolysis in Hypertensive Patients at Rest and During Exercise;American Journal of Cardiovascular Drugs;2019-02-04
3. What is the Real Efficacy of Beta-Blockers for the Treatment of Essential Hypertension?;Current Pharmaceutical Design;2017-12-04
4. Consuming a hypocaloric high fat low carbohydrate diet for 12weeks lowers C-reactive protein, and raises serum adiponectin and high density lipoprotein-cholesterol in obese subjects;Metabolism;2013-12
5. Potential therapeutic approaches for modulating expression and accumulation of defective lamin A in laminopathies and age-related diseases;Journal of Molecular Medicine;2012-10-23
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3